Ontology highlight
ABSTRACT:
SUBMITTER: Terezakis SA
PROVIDER: S-EPMC4251770 | biostudies-other | 2012 Oct
REPOSITORIES: biostudies-other
Terezakis Stephanie A SA Kasamon Yvette L YL
Critical reviews in oncology/hematology 20120329 1
Radiotherapeutic advances have contributed to the evolution of Hodgkin's lymphoma (HL) treatment paradigms. A reduction in radiation therapy (RT) field size and dose has the potential to significantly impact the therapeutic ratio by diminishing late toxicities while maintaining curability. Substantial progress in risk stratification has contributed to the development of tailored RT strategies which address both field design as well as dose. Technologic improvements have also enhanced the ability ...[more]